NEO-CONCEPT INTL GROUP HLD-A (NCI) Stock Fundamental Analysis
USA - NASDAQ:NCI - KYG6421C1208 - Common Stock
1.0517 USD
-0.05 (-4.39%)
Overall NCI gets a fundamental rating of 4 out of 10. We evaluated NCI against 48 industry peers in the Textiles, Apparel & Luxury Goods industry. While NCI has a great health rating, its profitability is only average at the moment. NCI does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
NCI had positive earnings in the past year.
NCI had a positive operating cash flow in the past year.
1.2 Ratios
NCI's Return On Assets of 6.96% is amongst the best of the industry. NCI outperforms 81.25% of its industry peers.
NCI has a Return On Equity of 16.61%. This is in the better half of the industry: NCI outperforms 72.92% of its industry peers.
NCI has a Return On Invested Capital of 10.62%. This is in the better half of the industry: NCI outperforms 70.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.96% | ||
| ROE | 16.61% | ||
| ROIC | 10.62% |
ROA(3y)13.46%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NCI's Profit Margin of 3.01% is in line compared to the rest of the industry. NCI outperforms 52.08% of its industry peers.
NCI's Profit Margin has improved in the last couple of years.
NCI has a worse Operating Margin (3.97%) than 62.50% of its industry peers.
NCI's Operating Margin has improved in the last couple of years.
NCI has a worse Gross Margin (20.90%) than 83.33% of its industry peers.
In the last couple of years the Gross Margin of NCI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.97% | ||
| PM (TTM) | 3.01% | ||
| GM | 20.9% |
OM growth 3Y39.9%
OM growth 5YN/A
PM growth 3Y14.71%
PM growth 5YN/A
GM growth 3Y30.72%
GM growth 5YN/A
2. Health
2.1 Basic Checks
NCI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
NCI has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for NCI has been reduced compared to a year ago.
2.2 Solvency
NCI has an Altman-Z score of 2.66. This is not the best score and indicates that NCI is in the grey zone with still only limited risk for bankruptcy at the moment.
NCI has a Altman-Z score (2.66) which is comparable to the rest of the industry.
NCI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.66 |
ROIC/WACC1.04
WACC10.22%
2.3 Liquidity
NCI has a Current Ratio of 1.85. This is a normal value and indicates that NCI is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.85, NCI perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
NCI has a Quick Ratio of 1.75. This is a normal value and indicates that NCI is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.75, NCI belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.75 |
3. Growth
3.1 Past
NCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1450.00%, which is quite impressive.
NCI shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.41% yearly.
The Revenue has grown by 24.91% in the past year. This is a very strong growth!
The Revenue has been decreasing by -0.68% on average over the past years.
EPS 1Y (TTM)1450%
EPS 3Y15.41%
EPS 5YN/A
EPS Q2Q%88.99%
Revenue 1Y (TTM)24.91%
Revenue growth 3Y-0.68%
Revenue growth 5YN/A
Sales Q2Q%35.28%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
NCI is valuated cheaply with a Price/Earnings ratio of 3.39.
97.92% of the companies in the same industry are more expensive than NCI, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.34. NCI is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.39 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NCI indicates a rather cheap valuation: NCI is cheaper than 95.83% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 3.58 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NCI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:NCI (11/12/2025, 8:00:01 PM)
1.0517
-0.05 (-4.39%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners0.46%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap4.27M
Revenue(TTM)314.92M
Net Income(TTM)9.47M
Analysts60
Price TargetN/A
Short Float %6.15%
Short Ratio0.05
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.39 | ||
| Fwd PE | N/A | ||
| P/S | 0.11 | ||
| P/FCF | N/A | ||
| P/OCF | 77.18 | ||
| P/B | 0.58 | ||
| P/tB | 0.77 | ||
| EV/EBITDA | 3.58 |
EPS(TTM)0.31
EY29.48%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)0.01
OCFY1.3%
SpS9.98
BVpS1.81
TBVpS1.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.96% | ||
| ROE | 16.61% | ||
| ROCE | 12.88% | ||
| ROIC | 10.62% | ||
| ROICexc | 11.73% | ||
| ROICexgc | 13.95% | ||
| OM | 3.97% | ||
| PM (TTM) | 3.01% | ||
| GM | 20.9% | ||
| FCFM | N/A |
ROA(3y)13.46%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.02%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y39.9%
OM growth 5YN/A
PM growth 3Y14.71%
PM growth 5YN/A
GM growth 3Y30.72%
GM growth 5YN/A
F-Score6
Asset Turnover2.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 874.89% | ||
| Cap/Sales | 6.03% | ||
| Interest Coverage | 3.77 | ||
| Cash Conversion | 2.93% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.75 | ||
| Altman-Z | 2.66 |
F-Score6
WACC10.22%
ROIC/WACC1.04
Cap/Depr(3y)320.67%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.94%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1450%
EPS 3Y15.41%
EPS 5YN/A
EPS Q2Q%88.99%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.91%
Revenue growth 3Y-0.68%
Revenue growth 5YN/A
Sales Q2Q%35.28%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y69.7%
EBIT growth 3Y38.95%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y63.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y100.88%
OCF growth 3Y-65.28%
OCF growth 5YN/A
NEO-CONCEPT INTL GROUP HLD-A / NCI FAQ
What is the fundamental rating for NCI stock?
ChartMill assigns a fundamental rating of 4 / 10 to NCI.
Can you provide the valuation status for NEO-CONCEPT INTL GROUP HLD-A?
ChartMill assigns a valuation rating of 3 / 10 to NEO-CONCEPT INTL GROUP HLD-A (NCI). This can be considered as Overvalued.
Can you provide the profitability details for NEO-CONCEPT INTL GROUP HLD-A?
NEO-CONCEPT INTL GROUP HLD-A (NCI) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for NCI stock?
The Price/Earnings (PE) ratio for NEO-CONCEPT INTL GROUP HLD-A (NCI) is 3.39 and the Price/Book (PB) ratio is 0.58.
Can you provide the financial health for NCI stock?
The financial health rating of NEO-CONCEPT INTL GROUP HLD-A (NCI) is 7 / 10.